Uncommon Therapeutics

📍 San Francisco, United States👥 3 employees💰 Last funded Apr 2025
Biotechnology Research🌐 uncommontherapeutics.com
Website LinkedIn
Uncommon Therapeutics is a disease focused biotech, developing multiple high‐value ($b) therapeutics per disease, by combining new tools and deep disease expertise to deliver cures.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Uncommon Therapeutics?
Uncommon Therapeutics has 1 investors on record on gritt.io.
When did Uncommon Therapeutics last raise funding?
The most recent investment in Uncommon Therapeutics recorded on gritt.io was in April 2025.
What industry is Uncommon Therapeutics in?
Uncommon Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Uncommon Therapeutics based?
Uncommon Therapeutics is headquartered in San Francisco, United States.